SCHOTT Pharma
Patrick Wolf is an accomplished professional in the field of chemical engineering, currently serving as the Head of Development for Drug Containment Solutions at SCHOTT Pharma since August 2022. Prior to this role, Patrick held several development and engineering positions within SCHOTT from December 2017 to July 2022, including Head of Development for Bulk & Sterile Solutions and Head of Product Engineering for Sterile & Bulk. Patrick’s career began at ETH Zürich, where a progression of roles, including Postdoctoral Research Fellow and various project management and engineering positions, were undertaken. Patrick holds a Doctor of Science in Chemical Engineering from ETH Zürich, as well as Master's degrees from ETH Zürich and the Massachusetts Institute of Technology, complemented by earlier academic work at the University of Wisconsin-Madison and a Bachelor's degree from ETH Zürich.
This person is not in any teams
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social